When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MGNX - MacroGenics files U.S. application for margetuximab for HER2+ breast cancer
MacroGenics Inc.
MacroGenics (MGNX+3.3%) has filed its U.S. marketing application seeking approval of margetuximab for the treatment of metastatic HER2-positive breast cancer (combined with chemo).
More news on: MacroGenics, Inc., Healthcare stocks news, Stocks on the move,